Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
What Pharmacists Should Understand When Assessing, Treating Patients With Ovarian Cancer With Rucaparib
Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, discusses what oncology pharmacists should understand about rucaparib when treating ovarian cancer.
Pharmacy Times interviewed Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, on what rucaparib is used to treat and how its mechanism of action works to fight cancer.
During the interview, Morris addressed what oncology pharmacists should understand when assessing and treating patients with ovarian cancer with rucaparib.
Related Videos
Related Content
Covalent BTK Inhibitors: A Review of the Evidence in Chronic Lymphocytic Leukemia
Richa Shah, PharmD, BCOP;Rebecca Pokorny, PharmD, BCPS, BCOP;Luisa Giannangelo, MBA, RPh;Cradesha Perry, PharmD, MBA;Adina Kagan, PharmD Candidate;Yuxi Lei, PharmD Candidate;Rezarta Lako, PharmD, BCPS;Jessie Modlin, PharmD, BCOP;Kevin Pang, PharmD
June 14th 2024Article
